Superluminal Medicines

Company Deals

Superluminal Collaborates With Eli Lilly on Small Molecule Therapeutics for Cardiometabolic Diseases

Fineline Cube Aug 15, 2025

Superluminal Medicines announced on August 14, 2025, a collaboration with Eli Lilly (NYSE: LLY) to...

Company Drug

Novo Nordisk semaglutide Alzheimer’s biomarkers fail primary endpoint

Company Medical Device

Acotec V-otter Microcatheter Secures NMPA Approval for TACE Procedures

Company Deals

Youjia-Bio Tongee-Medical Nucleic-Acid-Drug Partnership Targets Diabetes

Company Drug

Fosun-Pharma FXS0887 ATR-Inhibitor Gets NMPA Phase 1 Nod